Literature DB >> 25322559

[The interaction between ononin and human intestinal bacteria].

Wei Zhang, Shu Jiang, Da-Wei Qian, Er-Xin Shang, Han-Liang Guan, Hao Ren, Zhen-Hua Zhu, Jin-Ao Duan.   

Abstract

The study aims to screen the ability of the bacteria to metabolize ononin and assess the effect of ononin on the intestinal bacteria. Fresh human fecal sample was obtained from a healthy volunteer, diluted serially in sterile water and sixty-nine different bacterial colonies were picked out ultimately. UPLC-Q-TOF/MS with automated data analysis software (MetaboLynx) was applied to fast analysis of ononin metabolites. Furthermore, an E(max) precision microplate reader was employed to determine the growth situation of Enterococcous sp., Enterobacter sp., Lactobacilli sp., and Bifidobacteria sp. Results indicated that hydrogenation, demethylation, hydroxylation and deglycosylation were the major metabolic pathways of ononin by human intestinal bacteria in vitro. Ononin can inhibit the growth of pathogen such as Enterococcus sp., Enterobacter sp. and can promote the growth of probiotics such as Bifidobacteria sp. and Lactobacilli sp. This study suggested that intestinal bacteria have the metabolic effects of ononin and the biotransformation was completed by different bacteria. And ononin can affect the balance of intestinal flora and the degree of influence varies depending on the bacterial species and the concentration of ononin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25322559

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  4 in total

1.  Pharmacokinetic Difference of Six Active Constituents of Huangqi Liuyi Decoction between Control and Diabetic Nephropathy Mouse Models.

Authors:  Qun Wang; Ya Shi; Xingde Liu; Ting Liu; Yongjun Li; Xinli Song; Xiaolan Chen; Yang Jin; Wen Liu; Yonglin Wang; Zipeng Gong
Journal:  Int J Anal Chem       Date:  2022-05-25       Impact factor: 1.698

2.  Integrative metabolic and microbial profiling on patients with Spleen-yang-deficiency syndrome.

Authors:  Zhang Lin; Wu Ye; Xianpeng Zu; Haisheng Xie; Houkai Li; Yiping Li; Weidong Zhang
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

3.  Exploring the In Vivo Existence Forms (23 Original Constituents and 147 Metabolites) of Astragali Radix Total Flavonoids and Their Distributions in Rats Using HPLC-DAD-ESI-IT-TOF-MSn.

Authors:  Li-Jia Liu; Hong-Fu Li; Feng Xu; Hong-Yan Wang; Yi-Fan Zhang; Guang-Xue Liu; Ming-Ying Shang; Xuan Wang; Shao-Qing Cai
Journal:  Molecules       Date:  2020-11-26       Impact factor: 4.411

4.  A Novel Formononetin Derivative Promotes Anti-ischemic Effects on Acute Ischemic Injury in Mice.

Authors:  Lin Zhao; Jing Han; Jiaqi Liu; Kechen Fan; Tianjie Yuan; Ju Han; Liangliang Chen; Sen Zhang; Ming Zhao; Jinao Duan
Journal:  Front Microbiol       Date:  2021-12-14       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.